These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 8133532)

  • 1. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
    Kirnbauer R; Hubbert NL; Wheeler CM; Becker TM; Lowy DR; Schiller JT
    J Natl Cancer Inst; 1994 Apr; 86(7):494-9. PubMed ID: 8133532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
    J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
    [No Abstract]   [Full Text] [Related]  

  • 3. Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responses.
    Studentsov YY; Ho GY; Marks MA; Bierman R; Burk RD
    J Clin Microbiol; 2003 Jul; 41(7):2827-34. PubMed ID: 12843008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus (HPV) L1 and L1-L2 virus-like particle-based multiplex assays for measurement of HPV virion antibodies.
    Hernandez BY; Ton T; Shvetsov YB; Goodman MT; Zhu X
    Clin Vaccine Immunol; 2012 Sep; 19(9):1348-52. PubMed ID: 22761294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].
    Heim K; Christensen ND; Höpfl R; Wartusch B; Zeimet A; Larcher C; Ruth N; Bergant A; Pirschner G; Dierich MP
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():25-31. PubMed ID: 8672922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: correlation with virus-like particle IgG concentration.
    Bryan JT; Jansen KU; Lowe RS; Fife KH; McClowry T; Glass D; Brown DR
    J Med Virol; 1997 Nov; 53(3):185-8. PubMed ID: 9365880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase.
    Sehr P; Müller M; Höpfl R; Widschwendter A; Pawlita M
    J Virol Methods; 2002 Oct; 106(1):61-70. PubMed ID: 12367730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.
    Monroy-García A; Gómez-Lim MA; Weiss-Steider B; la Rosa GP; Hernández-Montes J; Pérez-Saldaña K; Tapia-Guerrero YS; Toledo-Guzmán ME; Santiago-Osorio E; Sanchez-Peña HI; Mora-García Mde L
    Virol J; 2011 Feb; 8():59. PubMed ID: 21306638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
    J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillomavirus-like particles for serology and vaccine development.
    Kirnbauer R
    Intervirology; 1996; 39(1-2):54-61. PubMed ID: 8957670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
    Marais DJ; Rose RC; Lane C; Kay P; Nevin J; Denny L; Soeters R; Dehaeck CM; Williamson AL
    J Med Virol; 2000 Apr; 60(4):403-10. PubMed ID: 10686023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus.
    Le Cann P; Touze A; Enogat N; Leboulleux D; Mougin C; Legrand MC; Calvet C; Afoutou JM; Coursaget P
    J Clin Microbiol; 1995 May; 33(5):1380-2. PubMed ID: 7615761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum IgG, IgM, and IgA reactivity to human papillomavirus types 11 and 6 virus-like particles in different gynecologic patient groups.
    Heim K; Christensen ND; Hoepfl R; Wartusch B; Pinzger G; Zeimet A; Baumgartner P; Kreider JW; Dapunt O
    J Infect Dis; 1995 Aug; 172(2):395-402. PubMed ID: 7542685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
    Petter A; Heim K; Guger M; Ciresa-Kö Nig A; Christensen N; Sarcletti M; Wieland U; Pfister H; Zangerle R; Höpfl R
    J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions.
    Sasagawa T; Inoue M; Lehtinen M; Zhang W; Gschmeissner SE; Hajibagheri MA; Finch J; Crawford L
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):403-10. PubMed ID: 8807204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
    Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations.
    Nonnenmacher B; Kruger Kjaer S; Svare EI; Scott JD; Hubbert NL; van den Brule AJ; Kirnbauer R; Walboomers JM; Lowy DR; Schiller JT
    Int J Cancer; 1996 Dec; 68(6):704-9. PubMed ID: 8980170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
    Marais D; Rose RC; Williamson AL
    J Med Virol; 1997 Feb; 51(2):126-31. PubMed ID: 9021543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.
    Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P
    J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
    Matsumoto K; Yoshikawa H; Yasugi T; Nakagawa S; Kawana K; Takeoka A; Yaegashi N; Iwasaka T; Kanazawa K; Taketani Y; Kanda T
    J Med Virol; 2003 Mar; 69(3):441-6. PubMed ID: 12526056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.